Doug Dewar

Doug Dewar has held various roles in the pharmaceutical industry, starting with Roche in 1987 and later transitioning to Genentech in 2010. Doug's responsibilities have included driving demand for different oncology products, launching new medications, and developing business opportunities. Doug has a Bachelor's degree in Biological Sciences from the University of California, Davis.